>Mlig455_038150 {Length: 1621} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=73.9]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=81.3, Expect=3e-16]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=80.1, Expect=7e-16]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=78.6, Expect=6e-16]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=77.4, Expect=7e-15]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=77.4, Expect=6e-15]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=77.4, Expect=5e-15]} {Mouse: ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=79.0, Expect=1e-15]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=78.6, Expect=2e-15]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=78.2, Expect=2e-15]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=77.4, Expect=3e-15]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=76.3, Expect=8e-15]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=75.9, Expect=1e-14]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=68.6, Expect=2e-12]} {Celegans: WBGene00000051, acr-12, AcetylCholine Receptor; Nicotinic acetylcholine receptor-like subunit ACR-12, [Score=89.7, Expect=2e-19]} {Smed: dd_Smed_v6_9799_0_1, dd_Smed_v6_9799_0_1, [Score=72.0, Expect=9e-14]} {RNA1310_107423}
ATGGCAATCAGTCTGCTGTTATTGTGGCTCCTGCTTCAATTGCAAATCACTGCTGCTGCTGCTGCGGCCAGCAACATCGG
CTCGTCCAGAGGGGCCGCTGCGGCGGCTGCCGCTGCGTCGTCGGGTCGTCATCAGGACGGCTCCGGTGGCGAGCTCGGCG
GCGGCGGAGGCTCAGGCCGGCTGGCATCGATGACGGACGGTGGCGGCGGCATGGGGCGCCTGTGCACGGATCACTGCTCG
GAAGGGTTGCGCAATTGCTCAGCTGAGCAGCGGGCCAAGGAGACACTGCTGTGCGGCTATGATCGGACGTCCAGACCGGT
GCTGCAGGGGGATGGCCAGATTCGTGTGCACATCGCTGTGGCTCTGTTTCATATTCTGGACGCGGATGAAAAGCATCAAA
CTTTGACGATACTGCTGTCAATCAGATTGCGGTGGACAGACGAACACCTGATTTGGCTGCCGGACGAGTTCAATGGCACC
CAGTCCATACATATCCCATCTGGCTCGATATGGACTCCTGATATTGTCATCTCCAACAGGTGCGTCTGCCTGTCTGTCTG
TCTGTCTGTCTGTTGTCTGTCTGTTGTCTGTCTGTCTGGCTGTTGTCTGTCTGTCTGGCTGTCTGTCTGTTGTCTGTCTG
TCTGGCTGTCTGTCTGTTTTCTGTTGTCTGTCTGTCTGTCTGTCTATCTGTCTATCTGTCTGTCTGTCCGTCTGTGTGTC
TGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTGTGTGTGTC
TGTCTTAGTGTCTGTCTGTGTGTGTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTATCTGTCTGCCTGTC
TGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTATCTGTCTGCCTGTCTGTCTGTCTGTCTGTC
TGTCTGTCTGTCTGTCTGTCTGTCTGTCTGACTCAATGTCTGTCTTTCTGTCTGGCTGTTGTCTGTTGTCTGTCTGTTGT
CTGTCTGTCTGGCTGTTGTCTGGCTGTCTGGCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGATTGTCTGTCTGTC
TGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTC
TGTCTGTCTGTCTGTCCGTCTGTCTGTCTGCCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTC
TGTCCGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTCTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTC
TGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTCTGTGTGTCTGTCTGTCTGTCTGTGTGTCTGTC
TGCCTGTCTGTCTGTCAGTCCTACAGTGAGTAGAGCTTGACAGTAGAGGGTCAGCATATTTACTAAGTTATGCTTACTAA
CCTATTCGGTACAATCCAATCTCGGGCCCCAGAAAGCTTTCAGCAGCATCAGTTGAATCCAATCAGTTTTTCAGCCTCAG
CGATCCGACAAAATTGGCTCGG